goodrx novo nordisk - Search News

Order byBest matchMost fresh

Novo Nordisk, GoodRx and Ozempic

GoodRx teams up with Novo Nordisk to make weight loss drugs more affordable

“Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,” Wendy Barnes, President and Chief Executive Officer of GoodRx, said in a news release...

· 1d · on MSN

Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash

· 3d · on MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

· 1d

Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025

“At the ESC congress, we are presenting new data substantiating the unique range of benefits semaglutide has on people with heart and kidney disease, as demonstrated in both clinical trials and in the...

· 1d

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

· 2d

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

3don MSN

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, jumped 5% through 9:55 a.m. ET Monday on a series of positive announcements for its GLP-1 products.

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk.